HIV Seroconversion Among People of Transgender or Gender Diverse Experience
For further information, please contact
Mark Brennan Ing
mi708@hunter.cuny.edu
People who are transgender and gender diverse (TGD), especially Black transgender women, are disproportionately at risk for HIV. Culturally appropriate HIV prevention targeting TGD populations, including pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), is critical in preventing avoidable HIV transmission. Research finds that transgender women hold favorable attitudes towards PrEP, but uptake of this HIV prevention method is low, for reasons that may include social stigma, fears that PrEP will interact with gender-affirming hormone therapy, or lack of access because of poverty, criminalization of sex work, homelessness, and lack of health insurance. The purpose of this study is to understand the experiences of the TGD population and the barriers to access or uptake of PrEP, as well as the role of social determinants of health, such as age, race/ethnicity, behavioral health, and housing stability in use of PrEP.
The study will employ a mixed-methods design using a collaborative community-based approach with Amida Care, Inc., the largest Medicaid managed care Special Needs Plan for people living with or at risk for HIV in the New York City metropolitan area. Our aim in Year One is to gain the perspective of people of TGD experience, both those who seroconverted (acquired HIV) in the past five years and those who are HIV negative, to understand how care engagement, access to and knowledge of PrEP, social determinants of health, and utilization of gender-affirming care are associated with seroconversion. Year Two involves a quantitative study to examine the association of social factors and use of gender-affirming medical care with PrEP and PEP use and related outcomes. We will synthesize the qualitative and quantitative findings to inform HIV prevention services and public health policy development relevant to people of transgender experience, and those who have trouble in PrEP adherence, to improve health equity in this population.
Brookdale’s executive director, Mark Brennan Ing, is the Principal Investigator on this study, which is funded by the New York State Department of Health AIDS Institute.